Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

IS-III active Short Implant

K-Number: K232049 · 2024-03-28

Decision Date2024-03-28
Product CodeDZE
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

IS-III active Short Implant is a medical device manufactured by Neobiotech Co., Ltd.. It received FDA 510(k) clearance on 2024-03-28 under approval number K232049. The device is classified under product code DZE. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the IS-III active Short Implant?

IS-III active Short Implant is a medical device that received FDA 510(k) clearance on 2024-03-28. It is manufactured by Neobiotech Co., Ltd.. The 510(k) number is K232049.

When was IS-III active Short Implant approved by the FDA?

IS-III active Short Implant received FDA 510(k) clearance on 2024-03-28, under approval number K232049.

What company makes IS-III active Short Implant?

IS-III active Short Implant is manufactured by Neobiotech Co., Ltd..

What is the FDA product code for IS-III active Short Implant?

The FDA product code for IS-III active Short Implant is DZE.

Related Clinical Trials

Other Devices by Neobiotech Co., Ltd.

View all 9 devices →

Related Devices (Code: DZE)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.